July 30, 2026 11:28 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Farmers storm Bhopal! Traffic crippled as protest over MSP intensifies | Supreme Court gives clean chit to Manmohan Singh in coal block scam case two years after death, accepts CBI closure report | Rahul Gandhi's 'student, idiot, andhbhakt' remark sparks uproar in Lok Sabha during anti-paper leak bill debate | Assam flood death toll climbs to 75; Over 3 lakh still affected as relief efforts intensify | 'You are simply useless': Kangana Ranaut hits back at CJP's Saurav Das in fresh Instagram attack | Assam floods: Death toll stays at 68 as over 5.24 lakh continue to battle deluge | 'Probe is meaningless if responsibility isn't fixed': Supreme Court slams Delhi Police over CJP protest crackdown | 'No protester will be left alone': CJP claims Centre shared FIR withdrawal copies after midnight talks | Bihar cop suspended after viral AK-47 firing video during NEET protest crackdown | After Dharmendra Pradhan's exit, 'E20 Janta Party' emerges, demands Nitin Gadkari's resignation over fuel policy
Serum Institute
PIB

Had a good interaction with team: Indian PM Narendra Modi tweets after visiting Serum Institute of India

| @indiablooms | Nov 29, 2020, at 12:38 am

Pune: Indian PM Narendra Modi on Saturday visited Pune's Serum Institute of India, which is working on the coronavirus vaccine, and interacted with the team at the Institute.

"They shared details about their progress so far on how they plan to further ramp up vaccine manufacturing," read a government statement.

In a tweet, the Prime Minister said, "Had a good interaction with the team at Serum Institute of India. They shared details about their progress so far on how they plan to further ramp up vaccine manufacturing. Also took a look at their manufacturing facility."  

The institute's CEO Adar Poonawala thannked PM and tweeted: "Thank you @narendramodi for visiting @SerumInstIndia . We share your vision and continue to work towards ensuring a safe and secure India."

The PM earlier in the day visited  Bharat Biotech International Limited (BBIL) at Genome Valley in Shamirpet and reviewed the progress on the manufacturing of indigenous COVID-19 vaccine 'Covaxin'.

In Ahmedabad, he reviewed the vaccine development process at the Zydus Cadila research centre in Changodar industrial area.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.